Cargando…
Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients
Landiolol is an ultra-short-acting β(1)-selective antagonist developed in Japan that was recently approved for the treatment of tachycardia in intensive care units (ICUs). This study investigated the protective effects of landiolol against the cardiovascular responses during bronchoscopic endotrache...
Autores principales: | Tochikubo, Junpei, Adachi, Yushi U, Ejima, Tadashi, Numaguchi, Atsushi, Matsuda, Naoyuki, Sato, Shigehito, Shiiya, Norihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267460/ https://www.ncbi.nlm.nih.gov/pubmed/25520823 http://dx.doi.org/10.1186/2052-0492-2-6 |
Ejemplares similares
-
Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009) -
Subcutaneous emphysema and ultrasound sonography
por: Kubodera, Toshi, et al.
Publicado: (2013) -
Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014) -
Laparoscopic splenectomy for a wandering spleen complicating gastric varices: report of a case
por: Sato, Masanori, et al.
Publicado: (2015) -
Asynchronous abdomino-parasacral resection of a giant pelvic lipoma protruding to the left buttock
por: Sato, Masanori, et al.
Publicado: (2014)